Gastrointestinal stromal tumor is a rare tumor which arises from the whole gastrointestinal tracts and most of it is detected in the stomach. It is uncommon with small intestine originated gastrointestinal stromal tumor and more uncommon with lymphatic metastasis. We experienced an unusual case of the small bowel gastrointestinal stromal tumor during experimental autopsy. Two primary tumors with central necrosis were detected in the ileum. The sizes of each tumor were 6.1×3.4×4.0 cm and 3.7×4.2×3.2 cm. There was extensive lymphatic metastasis on the greater omentum and mesenteric, iliac lymph nodes were also involved. With histologic findings, the eosinophilic spindle cells were densely distributed. Immunohistochemical findings were CD117 (-), CD34 (+), desmin (-), and S-100 protein (-). Therefore, we diagnosed the tumors as small bowel gastrointestinal stromal tumors with broad lymph node mestasis.
Introduction
Gastrointestinal stromal tumor (GIST) is very rare tumor arisen from gastrointestinal tract that constitutes 0.1%~3.0% of gastrointestinal malignant tumor. [1] [2] [3] [4] [5] GISTs may be occurred at the esophagus, stomach, small intestine, large intestine, anal canal, mesentery, greater omentum, and retorperitoneum. 6 The small intestine constitutes 80% of the length, and 90% of the mucosal surface area of the digestive tract. However, the tumors originated from the small intestine are very rare because of various reasons, such as rare exposure to carcinogens due to rapid transit of food materials and rapid turnover of the epithelia, alkaline environment of bowel contents, richness of immunoglobulin A, and inconsiderable intestinal bacterial flora. The tumors arisen from the small intestine accounts for 5% of the tumors occurred in the digestive tract and the malignant tumors of the small intestine constitutes 1%~2% of the malignancies of the digestive tract. Fifty percents of the small intestine derived malignant tumors are the adenocarcinoma, and less than 20% are the malignant GISTs. 7 In some cases, the researchers classified the leiomyoma and the leiomyosarcoma into the smooth muscle cell derived tumors or GISTs derived from the interstitial cell of Cajal. 8 However, in recent years, the pathologists clearly discriminate between the smooth muscle cell derived tumors and GISTs according to the immunohistochemical results. 9 GIST is occurred under the mucosa as a single mass. GIST may directly invade adjacent tissues or organs, and spread to other organs hematogenously, or metastasize to the liver or the omentum by peritoneal dissemination during the surgical operation. But lymphatic spread of GIST is very uncommon.
7
The authors experienced atypical case of GIST has two primary tumors in the ileum and extensive metastasis to the greater omentum and adjacent lymph nodes during cadaver dissection for medical students. Therefore, the authors report the case with review of the literatures.
GIST with Extensive Lymphatic Metastasis
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Case Report
A 53-year-old male cadaver was donated to our laboratory. He (Fig. 4) . The CD117 antigen was negative and the CD34 was partially positive in immunohistochemical assay (Fig. 5) . The desmin and the S-100 protein were not detected. Consequently, the authors diagnosed this tumor as the GIST with lymph node metastasis on the basis of the diagnostic guide of Hirota and Isozaki. 
Discussion
The stromal tumor developed in the gastrointestinal tract is very uncommon and that occurred within the small intestine is extremely rare. The most common site of GISTs in the digestive tract is the stomach and it comprises more than 50%. The second common site is the small intestine and the esophagus is the most rare primary lesion. 8 Within the small intestine, the jejunum is the most common region of primary GISTs and the ileum is the most uncommon region. The jejunal GISTs are half as many as that occurred in the duodenum and the ileum. 8, 11 In the past, the stromal tumors developed in the digestive tract had been regarded as the smooth muscle derived tumors and classified into subtypes base on the histological characteristics until the cellular origin was confirmed. Since then, the researchers discovered that the cellular origin of GISTs was the interstitial cell of Cajal and this cell mostly expressed c-kit gene product CD117. 9 Nowadays, GISTs are diagnosed by the immunohistochemical analysis of several tumor markers, such as CD117, CD34, desmin, and smooth muscle actin (SMA), and detection of the CD117 strongly supports confirm diagnosis of the GIST. 8, 9 The CD117 is detected at 95% of the GISTs. The CD34, SMA, S-100 protein, and desmin are positive at 60%~70%, 30%~40%, 5%, and 1%~2%
of GISTs, respectively. 10 Hirota and Isozaki 10 classified the stromal tumors into GISTs, smooth muscle tumors, and Schwann cell tumors based on the above data. They categorized the stromal tumors In this case, the authors diagnosed the tumors as GIST because it did not express the CD117, desmin, and S-100 protein, but expressed CD34 in abundance. It is well known that the SMA is detected around half of GISTs removed from the small intestine. 12 In our case, the tumors also expressed the SMA (Fig. 5 ).
Radical resection is recommended for the treatment of GISTs.
But localized resection and chemotherapy are performed in some cases. Recently, clinicians have been using the tyrosine kinase inhibitor STI-671 (imatinib mesylate, Gleevec; Novartis pharmaceuticals, Basel, Switzerland) to cure GISTs and it brings good results.
It is remarkable consensus that resection of lymph nodes are unnecessary because lymphatic spread of GISTs is very uncommon.
Morinaga et al. 13 proposed that complete resection of GISTs, even if they are small in size, is compulsory, but routine lymph node dissection is unnecessory. Pross et al. 14 
